Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congressional Drug Pricing Investigation Receives Boost From Rep. Bliley

Executive Summary

Congressional investigation of drug pricing is receiving support from an unlikely source, House Commerce Committee Chair Bliley (R-Va.)

You may also be interested in...



Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents

The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market

Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents

The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market

Warrick Albuterol Medicaid "Overpayments" Total $14.6 Mil. -Texas Argues

Warrick Pharmaceuticals is responsible for $14.6 mil. in albuterol reimbursement overpayments made by the Texas Medicaid Program, Texas Attorney General John Cornyn argued in a lawsuit filed Sept. 7 in Travis County, Texas state court.

Related Content

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel